JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258699

Human SPHK2 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SPHK2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1.

View Alternative Names

SK 2, SPHK2_HUMAN, SPK 2, Sphingosine kinase 2, Sphingosine kinase type 2

3 Images
Western blot - Human SPHK2 knockout HEK-293T cell lysate (AB258699)
  • WB

Lab

Western blot - Human SPHK2 knockout HEK-293T cell lysate (AB258699)

Lane 1 : Wild-type HEK-293T cell lysate 20 μg
Lane 2 : SPHK2 knockout HEK-293T cell lysate 20 μg
Lane 3 : HeLa cell lysate 20 μg
Lane 4 : Raji cell lysate 20 μg

Lanes 1 - 4 : Merged signal (red and green). Green - Anti-SPHK2 antibody observed at 68 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
Anti-SPHK2 antibody was shown to react with SPHK2 in wild-type HEK-293T cells in Western blot with loss of signal observed in SPHK2 knockout cell line ab267293 (SPHK2 knockout cell lysate ab258699). Wild-type HEK-293T and SPHK2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with anti-SPHK2 antibody and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Anti-SPHK2 antibody at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

SPHK2 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human SPHK2 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-sphk2-knockout-hek-293t-cell-line-ab267293'>ab267293</a>)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

Raji cell lysate at 20 µg

false

Sanger Sequencing - Human SPHK2 knockout HEK-293T cell lysate (AB258699)
  • Sanger seq

Unknown

Sanger Sequencing - Human SPHK2 knockout HEK-293T cell lysate (AB258699)

Homozygous : 1 bp insertion in exon1

Western blot - Human SPHK2 knockout HEK-293T cell lysate (AB258699)
  • WB

Supplier Data

Western blot - Human SPHK2 knockout HEK-293T cell lysate (AB258699)

Blocking and diluting buffer and concentration : 5% NFDM/TBST. In Western blot, ab320741 was shown to bind specifically to SPHK2. Target of interest was observed at 70 kDa in wild-type HEK293T cell lysate (Lane 1) with no signal observed at this size in SPHK2 knockout cell line (Lane 2) (Lane 2, knockout cell line ab267293/ knockout cell lysate ab258699). In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control  (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-SPHK2 antibody [EPR29189-33] (<a href='/en-us/products/primary-antibodies/sphk2-antibody-epr29189-33-ab320741'>ab320741</a>) at 1/1000 dilution

Lane 1:

Parental HEK293T(EDWT04) whole cell lysate at 20 µg

Lane 2:

Western blot - Human SPHK2 knockout HEK-293T cell lysate (ab258699) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 70 kDa,36 kDa

false

Exposure time: 180s

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258699-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SPHK2 knockout HEK293T cell lysate", "number":"AB258699-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258699-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SPHK2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SPHK2 also known as sphingosine kinase 2 is an enzyme responsible for the conversion of sphingosine to sphingosine-1-phosphate (S1P). This enzyme weighs approximately 68 kDa and is expressed in a wide range of tissues including liver kidney and brain. The catalytic activity of SPHK2 involves the phosphorylation of sphingosine which plays a part in the modulation of various cellular processes.
Biological function summary

SPHK2 influences cell growth survival and differentiation by generating sphingosine-1-phosphate a signaling lipid. It functions independently or in association with other proteins but it is not always a part of a larger complex. The generated S1P acts as a signaling molecule both inside and outside of cells affecting processes like apoptosis and inflammation.

Pathways

SPHK2 is a significant player in the sphingolipid signaling pathway and impacts the MAPK/ERK pathway. These pathways collectively regulate cellular proliferation and apoptosis. SPHK2 works in conjunction with SPHK1 a closely related sphingosine kinase in these signaling routes. These kinases together help to balance the levels of sphingosine and S1P which is essential for maintaining cellular homeostasis.

SPHK2 has been linked to cancer and inflammatory diseases. The overexpression of SPHK2 can result in increased levels of sphingosine-1-phosphate promoting cancer cell survival and resistance to chemotherapy. In addition SPHK2's involvement in inflammation suggests roles in conditions like rheumatoid arthritis where it might interact with TNF-α related signaling pathways. These connections highlight SPHK2 as a potential target for therapeutic intervention in such diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com